European Institute of Oncology Milan

The European Institute of Oncology Milan is a fast-growing comprehensive oncology center in Italy that has been combining education, treatment, and clinical research with a multidisciplinary approach since 1994. The clinic is a member of EU-LIFE, an alliance of leading life science research centers in Europe, and cooperates with the University of Milan and IFOM Experimental Oncology Campus. As a result, cancer professionals see patients from all over the world: from the Middle East, Central and Eastern Europe, South America, and Saudi Arabia. More than 300 doctors and 400 primary scientific employees serve approximately 150,000 patients and conduct more than 110,000 diagnostic examinations. The modern hospital building accommodates 230 beds in 9 highly specialized departments. In addition, the Milan Institute of Oncology is organized into three cross-departments (pathology and laboratory, imaging and radiological sciences, and experimental oncology) and three clinical areas (palliative care, genetics, and psycho-oncology). The modern hospital architecture, with much daylight and ample green space, creates comfortable living conditions. The Cambiare Passo Award demonstrates Milan's best integration and care for people with disabilities. The hospital also actively supports women's health thanks to its membership in the Bollini Rosa network. The clinic is at the forefront of all critical advances in breast surgery and performs more than 3,600 surgeries annually. Over the years, doctors have generated some original techniques and minimally invasive approaches, available only in the Institute of Oncology, thanks to the high professionalism of the staff, to improve the oncological and functional results of interventions with the most negligible surgical impact. Head and neck surgeons perform the most significant number of surgeries for malignant tumors annually than any other center.  Specialists were the first in Italy to offer conservative thyroid surgery, endoscopic non-surgical laryngeal surgery, and functional tongue surgery.  Also, the Milan European Institute of Oncology has extensive experience in laser microsurgery of early neoplasms of the larynx, avoiding radiation therapy. USGTCB biopsy of the larynx and base of the tongue is an original technique developed at the medical center more than 12 years ago, which allows for minimally invasive diagnosis without general anesthesia and complex, traumatic procedures. At the International Medical Travel Journal's annual awards ceremony, the European Institute of Oncology received a "high rating" as an international patient center. It is also the only European institution among the six best hospitals globally, recognized as a global "best practice" of care and awarded the Hospital Benchmarking Award. The oncology direction of the clinic determines the need to meet high international standards and have extensive experience in serving clients of varying degrees of difficulty. Treatment of otolaryngological, dermatological, gastroenterological, and gynecological oncological diseases, taking into account concomitant pathologies, is carried out according to the principle of teamwork of various disciplines using the most effective unique methods with care for the patient and his relatives.